Girgla Pharmaceuticals Private Limited
About Girgla Pharmaceuticals Private Limited
Data last updated:
Girgla Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 06 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2000PTC105084. Its GSTIN is 07AABCG5118P1ZD (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.6 Lakh. It is led by directors including Harbhajan Singh Girgla and Bhoopinder Jit Girgla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 65 – A Pratap Nagar Jail Road, New Delhi, Delhi, India – 110004.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.09 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net loss of ₹16.16 Lakh (net margin -48.8%) and EBITDA of -₹8.23 Lakh (EBITDA margin -24.9%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Girgla Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address65 – A Pratap Nagar Jail Road, New Delhi, Delhi, India – 110004
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of Girgla Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Girgla Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Girgla Pharmaceuticals Private Limited, buy the company report.
Financials of Girgla Pharmaceuticals Private Limited
FY 2024 filings availableGirgla Pharmaceuticals Private Limited reported revenue of ₹33.09 Lakh (down 46% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 46% fall in the latest year. EBITDA fell 129% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.9% | ||||
| Net Profit Margin | -48.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Girgla Pharmaceuticals Private Limited, buy the company report.
Board of directors of Girgla Pharmaceuticals Private Limited
Girgla Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harbhajan Singh Girgla Also directs: Girgla Clinic Private Limited | Director | 06 Apr 2000 | 26 Years 6 Months | Current |
| Bhoopinder Jit Girgla Also directs: Girgla Clinic Private Limited | Director | 06 Apr 2000 | 26 Years 6 Months | Current |
| Harsh Preet Singh Girgla Also directs: Girgla Clinic Private Limited | Director | 06 Apr 2000 | 26 Years 6 Months | Current |
Peer comparison
Girgla Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Girgla Pharmaceuticals Private Limitedthis company | ₹33.09 Lakh (FY 2024) | -₹16.16 Lakh | -48.8% | -46.0% | New Delhi, Delhi, India | |
| Mellow Pharmaceuticals Private Limited | ₹33 Lakh (FY 2022) | 17.0% | New Delhi, Delhi, India | |||
| Asolear Aesthetics Private Limited | ₹32.95 Lakh (FY 2024) | -7.0% | New Delhi, Delhi, India | |||
| Nhyoda Pharmaceuticals Private Limited | ₹32.92 Lakh (FY 2023) | Pune, Maharashtra, India |
To see the full peer comparison of Girgla Pharmaceuticals Private Limited, buy the company report.
Auditor
Girgla Pharmaceuticals Private Limited is audited by SUNDEEP SATPAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNDEEP SATPAL & ASSOCIATES | FY 2023 | 507170 |
Shareholding
The shareholding of Girgla Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Girgla Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Girgla Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Girgla Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Girgla Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCG5118P1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Girgla Pharmaceuticals Private Limited, buy the company report.
Recent activity
Girgla Pharmaceuticals Private Limited has 4 board changes on record since 2000: 3 appointments and 1 cessation. The latest: Harshdeep Singh Girgla ceased to be Director on 08 Jun 2024.
Frequently asked questions
Girgla Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 06 April 2000 (26+ years old) and is registered under CIN U74999DL2000PTC105084.
Girgla Pharmaceuticals has 3 current directors:
- Harbhajan Singh Girgla - Director
- Bhoopinder Jit Girgla - Director
- Harsh Preet Singh Girgla - Director
The latest financial statements of Girgla Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Girgla Pharmaceuticals is 07AABCG5118P1ZD, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Girgla Pharmaceuticals is U74999DL2000PTC105084. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Girgla Pharmaceuticals was incorporated on 06 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Girgla Pharmaceuticals by revenue are Mellow Pharmaceuticals Private Limited, Asolear Aesthetics Private Limited, Nhyoda Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harshdeep Singh Girgla ceased to be Director on 08 Jun 2024. Bhoopinder Jit Girgla was appointed as Director on 06 Apr 2000. Harbhajan Singh Girgla was appointed as Director on 06 Apr 2000. Girgla Pharmaceuticals has 4 board changes on record in total.
The registered office of Girgla Pharmaceuticals is at 65 – A Pratap Nagar Jail Road, New Delhi, Delhi, India – 110004.
Girgla Pharmaceuticals operates in the FMCG industry, in the personal care and skincare products segment.
The compliance status of Girgla Pharmaceuticals is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.